XML 21 R8.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Aug. 01, 2020
Aug. 03, 2019
Cash flows from operating activities:    
Net loss $ (270,926) $ (105,781)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 102,088 76,580
Share-based compensation 122,273 122,274
Amortization of acquired intangible assets 224,501 160,707
Amortization of inventory fair value adjustment associated with acquisitions 17,284 0
Restructuring related impairment charges 117,546 10,097
Other expense, net 14,910 14,534
Deferred income taxes (444) 2,374
Changes in assets and liabilities:    
Accounts receivable 8,804 40,376
Inventories 35,801 8,674
Prepaid expenses and other assets (3,015) (7,993)
Accounts payable 29,647 22,497
Accrued liabilities and other non-current liabilities 21,528 (80,117)
Accrued employee compensation (18,539) (25,266)
Net cash provided by operating activities 401,458 238,956
Cash flows from investing activities:    
Purchases of technology licenses (6,764) (1,522)
Purchases of property and equipment (52,883) (42,193)
Other, net 699 (389)
Net cash used in investing activities (58,948) (44,104)
Cash flows from financing activities:    
Repurchases of common stock (25,202) (64,272)
Proceeds from employee stock plans 48,234 81,314
Tax withholding paid on behalf of employees for net share settlement (56,714) (61,642)
Dividend payments to shareholders (79,882) (79,356)
Payments on technology license obligations (42,509) (28,324)
Principal payments of debt 0 (50,000)
Other, net (2,507) (1,486)
Net cash used in financing activities (158,580) (203,766)
Net increase (decrease) in cash and cash equivalents 183,930 (8,914)
Cash and cash equivalents at beginning of period 647,604 582,410
Cash and cash equivalents at end of period $ 831,534 $ 573,496